McEwen Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that McEwen Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.62M | Mar 17, 2026 |
| FY2025 | Sep 30, 2025 | $50.53M | Mar 17, 2026 |
| FY2025 | Jun 30, 2025 | $46.70M | Mar 17, 2026 |
| FY2025 | Mar 31, 2025 | $35.70M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $33.52M | Mar 17, 2026 |
| FY2025 | Sep 30, 2024 | $52.25M | Mar 17, 2026 |
| FY2025 | Jun 30, 2024 | $47.48M | Mar 17, 2026 |
| FY2025 | Mar 31, 2024 | $41.23M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $58.68M | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | $38.40M | Mar 14, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.40M | Mar 17, 2026 |
| FY2025 | Sep 30, 2025 | $7.82M | Mar 17, 2026 |
| FY2025 | Jun 30, 2025 | $12.28M | Mar 17, 2026 |
| FY2025 | Mar 31, 2025 | $10.07M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $363.0K | Mar 17, 2026 |
| FY2025 | Sep 30, 2024 | $13.80M | Mar 17, 2026 |
| FY2025 | Jun 30, 2024 | $10.76M | Mar 17, 2026 |
| FY2025 | Mar 31, 2024 | $6.01M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $13.05M | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | $3.76M | Mar 14, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.13M | Mar 17, 2026 |
| FY2025 | Sep 30, 2025 | ($462.0K) | Mar 17, 2026 |
| FY2025 | Jun 30, 2025 | $3.04M | Mar 17, 2026 |
| FY2025 | Mar 31, 2025 | ($6.27M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($8.23M) | Mar 17, 2026 |
| FY2025 | Sep 30, 2024 | ($2.08M) | Mar 17, 2026 |
| FY2025 | Jun 30, 2024 | ($13.00M) | Mar 17, 2026 |
| FY2025 | Mar 31, 2024 | ($20.38M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $138.45M | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | ($18.45M) | Mar 14, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($50.57M) | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | ($162.06M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | ($95.44M) | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | ($64.28M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($153.17M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | ($63.91M) | May 27, 2022 |
| FY2020 | Dec 31, 2018 | ($47.19M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | ($26.29M) | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $15.35M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.87M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $29.45M | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | ($39.64M) | Mar 17, 2026 |
| FY2024 | Dec 31, 2022 | ($56.58M) | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | ($20.06M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($27.87M) | Mar 14, 2023 |
| FY2021 | Dec 31, 2019 | ($39.53M) | May 27, 2022 |
| FY2020 | Dec 31, 2018 | $487.0K | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | ($27.65M) | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $7.45M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $62.34M | Feb 20, 2019 |
| FY2018 | Dec 31, 2017 | $5.08M | Feb 20, 2019 |
| FY2018 | Dec 31, 2016 | $1.17M | Feb 20, 2019 |
| FY2017 | Dec 31, 2015 | $777.0K | Feb 21, 2018 |
| FY2016 | Dec 31, 2014 | $2.79M | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $4.31M | Mar 11, 2016 |
| FY2014 | Dec 31, 2012 | $1.88M | Mar 9, 2015 |
| FY2013 | Dec 31, 2011 | $7.97M | Mar 10, 2014 |
| FY2012 | Dec 31, 2010 | $1.98M | Mar 11, 2013 |
| FY2011 | Dec 31, 2009 | $325.0K | Mar 12, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $820.22M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $664.62M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $657.24M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $528.72M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $525.34M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $499.94M | May 27, 2022 |
| FY2020 | Dec 31, 2019 | $631.22M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $616.94M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $592.13M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $498.32M | Feb 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.98M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $169.65M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $154.82M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $172.45M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $135.40M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $134.61M | May 27, 2022 |
| FY2020 | Dec 31, 2019 | $131.74M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $131.00M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $70.86M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $55.28M | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $365.33M | Mar 10, 2021 |
| FY2020 | Dec 31, 2019 | $499.48M | Mar 10, 2021 |
| FY2020 | Dec 31, 2018 | $485.95M | Mar 10, 2021 |
| FY2020 | Dec 31, 2017 | $521.27M | Mar 10, 2021 |
| FY2019 | Dec 31, 2016 | $443.04M | Mar 16, 2020 |
| FY2018 | Dec 31, 2015 | $418.29M | Feb 20, 2019 |
| FY2017 | Dec 31, 2014 | $441.22M | Feb 21, 2018 |
| FY2016 | Dec 31, 2013 | $746.77M | Mar 1, 2017 |
| FY2015 | Dec 31, 2012 | $889.59M | Mar 11, 2016 |
| FY2014 | Dec 31, 2011 | $219.30M | Mar 9, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.28B) | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | ($1.31B) | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | ($1.27B) | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | ($1.32B) | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | ($1.24B) | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | ($1.18B) | May 27, 2022 |
| FY2020 | Dec 31, 2019 | ($1.03B) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($971.48M) | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | ($929.61M) | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | ($918.97M) | Feb 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.02M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $13.69M | Mar 17, 2026 |
| FY2025 | Dec 31, 2023 | $23.02M | Mar 17, 2026 |
| FY2023 | Dec 31, 2022 | $39.78M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $54.29M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $20.84M | May 27, 2022 |
| FY2020 | Dec 31, 2019 | $46.45M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $15.76M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $27.15M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $37.44M | Feb 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $126.17M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | $40.00M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | $40.00M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $53.98M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $48.87M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | $48.16M | May 27, 2022 |
| FY2020 | Dec 31, 2019 | $19.76M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $24.60M | Mar 16, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 2 | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 14, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 17, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 2 | Mar 14, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 14, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.52M | Mar 17, 2026 |
| FY2025 | Dec 31, 2024 | 53.05M | Mar 17, 2026 |
| FY2024 | Dec 31, 2023 | 49.44M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | 47.43M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | 45.92M | Mar 14, 2023 |
| FY2021 | Dec 31, 2020 | 416.59M | May 27, 2022 |
| FY2020 | Dec 31, 2019 | 400.34M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 344.56M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | 337.05M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 299.57M | Feb 21, 2018 |